12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder
Titel:
12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder
Auteur:
Stein, Dan J. Khoo, Jon-Paul Ahokas, Antti Jarema, Marek Van Ameringen, Michael. Vavrusova, Livia Hӧschl, Cyril Bauer, Michael Bitter, Istvan Mosolov, Sergey N. Olivier, Valérie Matharan, Sophie Picarel-Blanchot, Françoise de Bodinat, Christian